Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2024

Open Access 01-12-2024 | Hypoglycemia | Research

Fear of hypoglycemia and illness perception in type II diabetes patients

Authors: Abdollahi Fariba, Mohammad Amerzadeh, Marjan Banazadeh, Saba Rashidi, Zahra Tayebi Myaneh

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

Hypoglycemia, a prevalent acute complication among individuals with type 2 diabetes (T2D), manifests with varied symptoms. Those with diabetes who have previously encountered hypoglycemic episodes commonly develop a Fear of Hyperglycemia (FOH). Illness perception (IP) significantly affects self-care behaviors and health outcomes in individuals diagnosed with T2D.

Objective

This study examined the correlation between IP and FOH among T2D patients and predictors of FOH.

Methods

The present study employed a descriptive-analytical design. The target population for this investigation comprised patients diagnosed T2D who sought medical care at the clinic and endocrinology departments of a hospital affiliated with Alborz University of Medical Sciences. The data collection period spanned from August 2019 to March 2021. A total of 300 individuals were included in the sample. Questionnaires were administered to measure both IP and FOH. Statistical analysis was conducted to examine the association between IP and FOH, as well as to identify the predictors of FOH.

Results

The results of the study indicated a statistically significant relationship between FOH and the mean score of IP among patients with diabetes (p = 0.001, r = 0.393), suggesting a moderate positive correlation between these variables. Additionally, the duration of illness, IP, and level of education were identified as variables that predicted FOH (p < 0.05).

Conclusion

The numerous factors that influence FOH in individuals diagnosed with T2D highlight the necessity for strategic planning and training initiatives aimed at enhancing IP and reducing FOH within this specific population. Healthcare providers should prioritize interventions that not only address patients’ concerns but also contribute to the improvement of their overall well-being. By implementing such interventions, healthcare providers can optimize diabetes management strategies and ultimately enhance patient outcomes.
Literature
1.
go back to reference GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402:203–34.CrossRef GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402:203–34.CrossRef
2.
go back to reference Emdin CA, Anderson SG, Woodward M, Rahimi K. Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies. J Am Coll Cardiol. 2015;6614:1552–62.CrossRef Emdin CA, Anderson SG, Woodward M, Rahimi K. Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies. J Am Coll Cardiol. 2015;6614:1552–62.CrossRef
3.
go back to reference Hazavehei SMM, KHANI JA, Hasanzadeh A, Amini S. The effect of educational program based on BASNEF model for eye care in non-insulin dependent diabetic patients. 2010. Hazavehei SMM, KHANI JA, Hasanzadeh A, Amini S. The effect of educational program based on BASNEF model for eye care in non-insulin dependent diabetic patients. 2010.
4.
go back to reference DeCarlo K, Wallia A. Inpatient management of T2DM and hyperglycemia in older adults. Curr Diab Rep. 2019;1910:1–9. DeCarlo K, Wallia A. Inpatient management of T2DM and hyperglycemia in older adults. Curr Diab Rep. 2019;1910:1–9.
5.
go back to reference Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes. 2006;24(3):115–21.CrossRef Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes. 2006;24(3):115–21.CrossRef
6.
go back to reference Ligthelm RJ, Kaiser M, Vora J, Yale JF. Insulin use in elderly adults: risk of hypoglycemia and strategies for care. J Am Geriatr Soc. 2012;60(8):1564–70.CrossRefPubMed Ligthelm RJ, Kaiser M, Vora J, Yale JF. Insulin use in elderly adults: risk of hypoglycemia and strategies for care. J Am Geriatr Soc. 2012;60(8):1564–70.CrossRefPubMed
7.
go back to reference Erol O, Enc N. Hypoglycemia fear and self-efficacy of Turkish patients receiving insulin therapy. Asian Nurs Res. 2011;54:222–8.CrossRef Erol O, Enc N. Hypoglycemia fear and self-efficacy of Turkish patients receiving insulin therapy. Asian Nurs Res. 2011;54:222–8.CrossRef
8.
go back to reference Sun C-A. The experience and the meaning of hypoglycemia to Cambodian diabetes patients: A qualitative study conducted in Phnom Penh, Cambodia. 2014. Sun C-A. The experience and the meaning of hypoglycemia to Cambodian diabetes patients: A qualitative study conducted in Phnom Penh, Cambodia. 2014.
9.
go back to reference Rossi MC, Nicolucci A, Ozzello A, Gentile S, Aglialoro A, Chiambretti A et al. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutr Metabolism Cardiovasc Dis. 2019;29(7):736–43. Rossi MC, Nicolucci A, Ozzello A, Gentile S, Aglialoro A, Chiambretti A et al. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutr Metabolism Cardiovasc Dis. 2019;29(7):736–43.
10.
go back to reference Jing X, Chen J, Dong Y, Han D, Zhao H, Wang X, et al. Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis. Health Qual Life Outcomes. 2018;161:1–14. Jing X, Chen J, Dong Y, Han D, Zhao H, Wang X, et al. Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis. Health Qual Life Outcomes. 2018;161:1–14.
11.
go back to reference Green L, Feher M, Catalan J. Fears and phobias in people with diabetes. Diab/Metab Res Rev. 2000;16(4):287–93. Green L, Feher M, Catalan J. Fears and phobias in people with diabetes. Diab/Metab Res Rev. 2000;16(4):287–93.
12.
go back to reference Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, Clarke W. Assessing fear of hypoglycemia in children with type 1 diabetes and their parents. Diabetes Manage [London England]. 2011;1(6):627. Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, Clarke W. Assessing fear of hypoglycemia in children with type 1 diabetes and their parents. Diabetes Manage [London England]. 2011;1(6):627.
13.
go back to reference Wu F-L, Juang J-H, Lin C-H. Development and validation of the hypoglycaemia problem-solving scale for people with diabetes mellitus. J Int Med Res. 2016;443:592–604.CrossRef Wu F-L, Juang J-H, Lin C-H. Development and validation of the hypoglycaemia problem-solving scale for people with diabetes mellitus. J Int Med Res. 2016;443:592–604.CrossRef
14.
go back to reference Kugbey N, Asante KO, Adulai K. Illness perception, diabetes knowledge and self-care practices among type-2 diabetes patients: a cross-sectional study. BMC Res Notes. 2017;101:1–7. Kugbey N, Asante KO, Adulai K. Illness perception, diabetes knowledge and self-care practices among type-2 diabetes patients: a cross-sectional study. BMC Res Notes. 2017;101:1–7.
15.
go back to reference Kugbey N, Atindanbila S, Nyarko K, Atefoe EA. T2DM patients’ demographic characteristics as moderators of the relationship between diabetes perception and psychological distress. 2015. Kugbey N, Atindanbila S, Nyarko K, Atefoe EA. T2DM patients’ demographic characteristics as moderators of the relationship between diabetes perception and psychological distress. 2015.
16.
go back to reference Al-Kayyis HK, Perwitasari DA. Illness perception and quality of life in type 2 diabetes mellitus patients in Lampung, Indonesia. Global J Health Sci. 2018;10(7):136–40. Al-Kayyis HK, Perwitasari DA. Illness perception and quality of life in type 2 diabetes mellitus patients in Lampung, Indonesia. Global J Health Sci. 2018;10(7):136–40.
17.
go back to reference Broadbent E, Donkin L, Stroh JC. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care. 2011;34(2):338–40. Broadbent E, Donkin L, Stroh JC. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care. 2011;34(2):338–40.
18.
go back to reference Petriček G, Vrcić-Keglević M, Vuletić G, Cerovečki V, Ožvačić Z, Murgić L. Illness perception and cardiovascular risk factors in patients with type 2 diabetes: cross-sectional questionnaire study. Croatian Med J. 2009;50(6):583–93.CrossRef Petriček G, Vrcić-Keglević M, Vuletić G, Cerovečki V, Ožvačić Z, Murgić L. Illness perception and cardiovascular risk factors in patients with type 2 diabetes: cross-sectional questionnaire study. Croatian Med J. 2009;50(6):583–93.CrossRef
19.
go back to reference Mc Sharry J, Moss-Morris R, Kendrick T. Illness perceptions and glycaemic control in diabetes: a systematic review with meta‐analysis. Diabetic Medicine. 2011;28(11):1300–1310. Mc Sharry J, Moss-Morris R, Kendrick T. Illness perceptions and glycaemic control in diabetes: a systematic review with meta‐analysis. Diabetic Medicine. 2011;28(11):1300–1310.
20.
go back to reference Martyn-Nemeth P, et al. Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention-a review. J Diabetes Complicat. 2016;30(1):167–77.CrossRef Martyn-Nemeth P, et al. Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention-a review. J Diabetes Complicat. 2016;30(1):167–77.CrossRef
21.
go back to reference Al Hayek AA et al. Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Principles Pract. 2015;24(3):222–30. Al Hayek AA et al. Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Principles Pract. 2015;24(3):222–30.
22.
go back to reference Gonder-Frederick L. Fear of hypoglycemia: a review. Diabet Hypoglycemia. 2013;53:3–11. Gonder-Frederick L. Fear of hypoglycemia: a review. Diabet Hypoglycemia. 2013;53:3–11.
23.
go back to reference Hapunda G, et al. Correlates of fear of hypoglycemia among patients with type 1 and 2 diabetes mellitus in outpatient hospitals in Zambia. Int J Diabetes Developing Ctries. 2020;40(4):619–26.CrossRef Hapunda G, et al. Correlates of fear of hypoglycemia among patients with type 1 and 2 diabetes mellitus in outpatient hospitals in Zambia. Int J Diabetes Developing Ctries. 2020;40(4):619–26.CrossRef
24.
go back to reference Yap CKWM, Lim KK. Illness perception of anxiety patients in primary care in Singapore. Indian J Psychol Med. 2019;41(1):75–80. Yap CKWM, Lim KK. Illness perception of anxiety patients in primary care in Singapore. Indian J Psychol Med. 2019;41(1):75–80.
25.
go back to reference Kępiński, AZn. związane ze stresami pod postacią somatyczną [F40-F48]. In Gałecki P. & Szulc A, editors, Psychiatria. Edra Urban & Partner. 2020. [1st ed, pp. 237–278. Kępiński, AZn. związane ze stresami pod postacią somatyczną [F40-F48]. In Gałecki P. & Szulc A, editors, Psychiatria. Edra Urban & Partner. 2020. [1st ed, pp. 237–278.
26.
go back to reference Wredling RA, Theorell PG, Roll HM, Lins PE, Adamson U. K. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care. 1992;154:518–21.CrossRef Wredling RA, Theorell PG, Roll HM, Lins PE, Adamson U. K. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care. 1992;154:518–21.CrossRef
27.
go back to reference McCarthy MM, WR, Gholson G, Grey M. Diabetes distress, depressive symptoms, and cardiovascular health in adults with type 1 diabetes. Nurs Res. 2019;68:445–52.CrossRefPubMedPubMedCentral McCarthy MM, WR, Gholson G, Grey M. Diabetes distress, depressive symptoms, and cardiovascular health in adults with type 1 diabetes. Nurs Res. 2019;68:445–52.CrossRefPubMedPubMedCentral
28.
go back to reference Li SFL, Lee A, Hayter M, Zhang L, Bi Y et al. The association between diabetes-related distress and fear of hypoglycaemia in patients with type 2 diabetes mellitus: a cross-sectional descriptive study. Nurs. 2021;Open 00:1–10. Li SFL, Lee A, Hayter M, Zhang L, Bi Y et al. The association between diabetes-related distress and fear of hypoglycaemia in patients with type 2 diabetes mellitus: a cross-sectional descriptive study. Nurs. 2021;Open 00:1–10.
29.
go back to reference Anderbro T, G-FL, Bolinder J, Lins PE, Wredling R, Moberg E, et al. Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors. Acta Diabetol. 2015;52:581–9.CrossRefPubMed Anderbro T, G-FL, Bolinder J, Lins PE, Wredling R, Moberg E, et al. Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors. Acta Diabetol. 2015;52:581–9.CrossRefPubMed
30.
31.
go back to reference Huang JDS, Xiong S, Liu Z. The mediating effects of diabetes distress, anxiety, and cognitive fusion on the association between neuroticism and fear of hypoglycemia in patients with type 2 diabetes. Front Psychol. 2021;12:697051.CrossRefPubMedPubMedCentral Huang JDS, Xiong S, Liu Z. The mediating effects of diabetes distress, anxiety, and cognitive fusion on the association between neuroticism and fear of hypoglycemia in patients with type 2 diabetes. Front Psychol. 2021;12:697051.CrossRefPubMedPubMedCentral
32.
go back to reference Momeni M, Ziaee A, Ghorbani A. Predictors of hypoglycemia fear in patients with type 2 diabetes under treatment of oral anti hyperglycemic agents. Iran J Endocrinol Metabolism. 2016;181:28–36. Momeni M, Ziaee A, Ghorbani A. Predictors of hypoglycemia fear in patients with type 2 diabetes under treatment of oral anti hyperglycemic agents. Iran J Endocrinol Metabolism. 2016;181:28–36.
33.
go back to reference Nur KRM. Illness perception and cardiovascular health behavior among persons with ischemic heart disease in Indonesia. Int J Nurs Sci. 2018;5(2):174–80. Nur KRM. Illness perception and cardiovascular health behavior among persons with ischemic heart disease in Indonesia. Int J Nurs Sci. 2018;5(2):174–80.
34.
go back to reference Yousefi ASF, Dehestani M, Barghi Irani Z. The relationship between quality of life [QoL] and psychological capital with illness perception in MS patients. Health Psychol. 2012:12:10–12 [Persian]. Yousefi ASF, Dehestani M, Barghi Irani Z. The relationship between quality of life [QoL] and psychological capital with illness perception in MS patients. Health Psychol. 2012:12:10–12 [Persian].
35.
go back to reference Lam AYR, Xin X, Tan WB, Gardner DS-L, Goh S-Y. Psychometric validation of the hypoglycemia fear survey-II [HFS-II] in Singapore. BMJ Open Diabetes Research and Care. 2017;5(1):e000329. Lam AYR, Xin X, Tan WB, Gardner DS-L, Goh S-Y. Psychometric validation of the hypoglycemia fear survey-II [HFS-II] in Singapore. BMJ Open Diabetes Research and Care. 2017;5(1):e000329.
36.
go back to reference Wang Y, Zeng Z, Ding J, Yuan R, Wang R, Zhang Y, et al. Fear of hypoglycaemia among patients with type 2 diabetes mellitus: a cross-sectional study. Sci Rep. 2021;111:1–8. Wang Y, Zeng Z, Ding J, Yuan R, Wang R, Zhang Y, et al. Fear of hypoglycaemia among patients with type 2 diabetes mellitus: a cross-sectional study. Sci Rep. 2021;111:1–8.
37.
go back to reference Chun M, Di B, Meijun WW. Status and influencing factors of fear of hypoglycemia among patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus. 2015;7(4):235–40. Chun M, Di B, Meijun WW. Status and influencing factors of fear of hypoglycemia among patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus. 2015;7(4):235–40.
38.
go back to reference Irvine AA, Cox D, Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol. 1992;11(2):135. Irvine AA, Cox D, Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol. 1992;11(2):135.
39.
go back to reference Ngetich E, Pateekhum C, Hashmi A et al. Illness perceptions, self-care practices, and glycemic control among type 2 diabetes patients in Chiang Mai, Thailand. Arch Public Health. 2022;80(134). Ngetich E, Pateekhum C, Hashmi A et al. Illness perceptions, self-care practices, and glycemic control among type 2 diabetes patients in Chiang Mai, Thailand. Arch Public Health. 2022;80(134).
40.
go back to reference Naser AY, Wong IC, Whittlesea C, Alwafi H, Abuirmeileh A, Alsairafi ZK et al. Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: a multinational cross-sectional study. PLoS ONE. 2019;14(10):e0222275. Naser AY, Wong IC, Whittlesea C, Alwafi H, Abuirmeileh A, Alsairafi ZK et al. Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: a multinational cross-sectional study. PLoS ONE. 2019;14(10):e0222275.
41.
go back to reference Hapunda G, Abubakar A, Pouwer F, Van De Vijver F. Correlates of fear of hypoglycemia among patients with type 1 and 2 diabetes mellitus in outpatient hospitals in Zambia. Int J Diabetes Developing Ctries. 2020;40(4):619–26. Hapunda G, Abubakar A, Pouwer F, Van De Vijver F. Correlates of fear of hypoglycemia among patients with type 1 and 2 diabetes mellitus in outpatient hospitals in Zambia. Int J Diabetes Developing Ctries. 2020;40(4):619–26.
42.
go back to reference Majaliwa ES, Elusiyan B, Adesiyun OO, Laigong P, Adeniran AK, Kandi CM, et al. Type 1 diabetes mellitus in the African population: epidemiology and management challenges. Acta Biomed. 2008;793:255–9. Majaliwa ES, Elusiyan B, Adesiyun OO, Laigong P, Adeniran AK, Kandi CM, et al. Type 1 diabetes mellitus in the African population: epidemiology and management challenges. Acta Biomed. 2008;793:255–9.
43.
go back to reference Ahola AJ, Saraheimo M, Freese R, Mäkimattila S, Forsblom C, Groop P-H, Group FS. Fear of hypoglycaemia and self-management in type 1 diabetes. J Clin Translational Endocrinol. 2016;4:13–8.CrossRef Ahola AJ, Saraheimo M, Freese R, Mäkimattila S, Forsblom C, Groop P-H, Group FS. Fear of hypoglycaemia and self-management in type 1 diabetes. J Clin Translational Endocrinol. 2016;4:13–8.CrossRef
44.
go back to reference Mc Sharry J, Moss-Morris R, Kendrick T. Illness perceptions and glycaemic control in diabetes: a systematic review with meta‐analysis. Diabet Med. 2011;2811:1300–10.CrossRef Mc Sharry J, Moss-Morris R, Kendrick T. Illness perceptions and glycaemic control in diabetes: a systematic review with meta‐analysis. Diabet Med. 2011;2811:1300–10.CrossRef
45.
go back to reference Malkani S, Kotwal A. Frequency and predictors of self-reported hypoglycemia in insulin-treated diabetes. Journal of diabetes research. 2017;2017. Malkani S, Kotwal A. Frequency and predictors of self-reported hypoglycemia in insulin-treated diabetes. Journal of diabetes research. 2017;2017.
46.
go back to reference Al Hayek AA, Robert AA, Braham RB, Issa BA, Al Sabaan FS. Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Principles Pract. 2015;24(3):222–30. Al Hayek AA, Robert AA, Braham RB, Issa BA, Al Sabaan FS. Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Principles Pract. 2015;24(3):222–30.
47.
go back to reference Aarthun A, Akerjordet K. Parent participation in decision-making in health‐care services for children: an integrative review. J Nurs Adm Manag. 2014;22(2):177–91. Aarthun A, Akerjordet K. Parent participation in decision-making in health‐care services for children: an integrative review. J Nurs Adm Manag. 2014;22(2):177–91.
48.
go back to reference Lüddeke HJ, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P et al. PREDICTIVE™–a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metabolism. 2007;9(3):428–34. Lüddeke HJ, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P et al. PREDICTIVE™–a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metabolism. 2007;9(3):428–34.
49.
go back to reference Kilpatrick E, Rigby A, Goode K, Atkin S. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia. 2007;5012:2553–61.CrossRef Kilpatrick E, Rigby A, Goode K, Atkin S. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia. 2007;5012:2553–61.CrossRef
Metadata
Title
Fear of hypoglycemia and illness perception in type II diabetes patients
Authors
Abdollahi Fariba
Mohammad Amerzadeh
Marjan Banazadeh
Saba Rashidi
Zahra Tayebi Myaneh
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01548-x

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.